Bergenhem Nils 4
4 · CPEX Pharmaceuticals, Inc. · Filed Apr 7, 2011
Insider Transaction Report
Form 4
Bergenhem Nils
Chief Scientific Officer
Transactions
- Disposition to Issuer
Common Stock
2011-04-05−13,875→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2011-04-05−17,500→ 0 totalExercise: $15.60Exp: 2020-02-01→ Common Stock (17,500 underlying) - Tax Payment
Common Stock
2011-04-05$27.25/sh−10,018$272,991→ 13,875 total - Exercise/Conversion
Common Stock
2011-04-05+17,500→ 23,893 total
Footnotes (3)
- [F1]17,500 options had an exercise price of $15.6000
- [F2]Pursuant to the Agreement and Plan of Merger between CPEX Pharmaceuticals, inc., FCB I Holdings Inc. and FCB I Acquisition Corp. dated January 3, 2011 (the "Merger Agreement"), each share of CPEX common stock was exchanged for $27.25. .
- [F3]This option is fully-vested.